Formulary Search Results for: CALCIUM AND VITAMIN D
8.3.1 Oestrogens - View Category
8.3 Sex hormones and hormone antagonists in malignant disease - View Category
Restrictions: The treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases is restricted to specialist use in accordance with regional protocol (in development) when the service infrastructure is in place to support the safe delivery of this treatment.
7.2.2 Vaginal and vulval infections - View Category
Restrictions:
The treatment of bacterial vaginosis is restricted to use in patients for whom the initial treatment is not effective or well tolerated.
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Restrictions:
Desmopressin oral lyophilisate for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults is restricted to specialist initiation by a consultant gynaecologist/urogynaecologist for use in patients aged 65 years and above (also see prescribing notes below).
Prescribing Notes:
- A positive diagnosis should be made following analysis of a 3-day volume chart
- Assessment of efficacy is required every 3 months
- Monitoring arrangements will be the responsibility of secondary care
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Pelvic floor exercises are considered the first line treatment for stress incontinence in women.
6.4.2 Male sex hormones and antagonists - View Category
5.1.3 Tetracyclines - View Category
Prescribing Notes:
Doxycycline is no more effective than oxytetracycline and is several times more expensive. Uses include sinusitis and pelvic inflammatory disease.
5.3.1.1 Nucleoside reverse transcriptase inhibitors - View Category
Restrictions:
Restricted to use by HIV specialists.
Prescribing Notes:
For treatment of hepatitis B see section 5.3.3.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
Restricted to use by HIV specialists.
Prescribing Notes:
Please note: Only this combination preparation containing cobicistat is included in the Formulary. Cobicistat tablets as a separate preparation (Tybost®) are not recommended for use by the Scottish Medicines Consortium and are non-Formulary.